2.
Percentage of SELDI-MS studies performed to date (Mid Jan 2007)
Cancer type | % of studies |
---|---|
Breast | 16.3% |
Colon | 3.6% |
Colorectal | 8.2% |
Glioma | 2.8% |
Hepatocellular/liver | 8.9% |
Kidney/renal | 4.1% |
Laryngeal | 0.4% |
Leukaemia/CLMC | 2% |
Ovarian | 10.2% |
Thyroid | 1.2% |
Bladder | 4.1% |
Pancreas | 2.8% |
Lung | 2.8% |
Head and neck | 4% |
Endometrial | 1.6% |
Brain | 1.2% |
Melanoma | 1.6% |